Owner Bayer HealthCare AG

Inventors Markova, Svetlana; Golz, Stefan; Vysotski, Eugene; Frank, Ludmila; Kalthof, Bernd

Agent Davies Collison Cave

Pub. Number AU-B-2002224876

PCT Pub. Number WO02/42470

Priority 10058091 23.11.00 DE

Filing date 22 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 5 April 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 15/53 (2006.01) Mutation or genetic engineering - Oxidoreductases (1)

C12Q 1/66 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving luciferase